US 11077077
Therapeutic compounds, formulations, and uses thereof
granted A61KA61K31/18A61K47/10
Quick answer
US patent 11077077 (Therapeutic compounds, formulations, and uses thereof) held by Tvardi Therapeutics, Inc. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tvardi Therapeutics, Inc.
- Grant date
- Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/18, A61K47/10, A61K47/26, A61K47/44